SCHEMBL23210666

SCHEMBL23210666

COC(=O)c1ccc(Oc2ccc(C3[C@H]4C[C@@H]5C[C@@H](C[C@H]3C5)C4)cc2)nc1

nearest known ligand 0.51

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.51
P2RX3 P56373 2/20 0.42
MAPK1 P28482 2/20 0.42
POLB P06746 1/20 0.41
KDM4E B2RXH2 2/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
ALOX5AP P20292 1/20 0.40
FEN1 P39748 1/20 0.40
SMN1; SMN2 Q16637 2/20 0.39
ALDH1A1 P00352 1/20 0.39
OPRM1 P35372 2/20 0.38
OPRK1 P41145 2/20 0.38
OPRD1 P41143 1/20 0.38
HRH3 Q9Y5N1 4/20 0.38
PDE4B Q07343 1/20 0.37
TSHR P16473 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23210665 1.00 LMNA (0.51) LMNAP2RX3MAPK1POLBKDM4E
SCHEMBL21656546 0.88 PDE4B (0.51) LMNAP2RX3MAPK1POLBKDM4E
SCHEMBL23210615 0.88 PDE4B (0.51) LMNAP2RX3MAPK1POLBKDM4E
SCHEMBL21628510 0.87 OPRM1 (0.49) LMNAPOLBSMN1; SMN2OPRM1OPRK1
SCHEMBL21628508 0.87 OPRM1 (0.49) LMNAPOLBSMN1; SMN2OPRM1OPRK1
SCHEMBL23210687 0.87 MAPT (0.43) POLBL3MBTL1SMN1; SMN2OPRM1OPRK1
SCHEMBL23210684 0.87 MAPT (0.43) POLBL3MBTL1SMN1; SMN2OPRM1OPRK1
SCHEMBL21628892 0.86 POLB (0.43) LMNAPOLBSMN1; SMN2OPRM1OPRK1
SCHEMBL21628894 0.86 POLB (0.43) LMNAPOLBSMN1; SMN2OPRM1OPRK1
SCHEMBL21628647 0.86 OPRM1 (0.50) OPRM1OPRK1OPRD1HRH3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12600696-B2 Aromatic compounds Xeniopro GmbH (DE) 2026-04-14 US disclosed
US-20230150923-A1 NOVEL AROMATIC COMPOUNDS Xeniopro GmbH (DE) 2023-05-18 US disclosed
US-20210107863-A2 NOVEL AROMATIC COMPOUNDS Xeniopro GmbH (DE) 2021-04-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230150923-A1 NOVEL AROMATIC COMPOUNDS AHR, TYR, MUSK LMNA 3327/4885P2RX3 1886/4885MAPK1 3508/4885
US-20210107863-A2 NOVEL AROMATIC COMPOUNDS AHR, TYR, MUSK LMNA 3327/4885P2RX3 1886/4885MAPK1 3508/4885
US-12600696-B2 Aromatic compounds CCR1, CCRL2, AHR LMNA 832/4885P2RX3 2895/4885MAPK1 2406/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.